Mostra el registre parcial de l'element

dc.contributor.authorRodon, Jordi
dc.contributor.authorMykytyn, Anna Z.
dc.contributor.authorCantero, Guillermo
dc.contributor.authorAlbulescu, Irina C.
dc.contributor.authorBosch, Berend-Jan
dc.contributor.authorBrix, Alexander
dc.contributor.authorAudonnet, Jean-Christophe
dc.contributor.authorBensaid, Albert
dc.contributor.authorVergara-Alert, Júlia
dc.contributor.authorHaagmans, Bart L.
dc.contributor.authorSegalés, Joaquim
dc.contributor.otherProducció Animalca
dc.date.accessioned2022-09-27T08:26:05Z
dc.date.available2022-09-27T08:26:05Z
dc.date.issued2022-06-24
dc.identifier.citationRodon, Jordi, Anna Z. Mykytyn, Guillermo Cantero, Irina C. Albulescu, Berend-Jan Bosch, Alexander Brix, and Jean-Christophe Audonnet et al. 2022. "Protective Efficacy Of An RBD-Based Middle East Respiratory Syndrome Coronavirus (MERS-Cov) Particle Vaccine In Llamas". One Health Outlook 4 (1). doi:10.1186/s42522-022-00068-9.ca
dc.identifier.issn2524-4655ca
dc.identifier.urihttp://hdl.handle.net/20.500.12327/1922
dc.description.abstractOngoing outbreaks of Middle East respiratory syndrome coronavirus (MERS-CoV) continue posing a global health threat. Vaccination of livestock reservoir species is a recommended strategy to prevent spread of MERS-CoV among animals and potential spillover to humans. Using a direct-contact llama challenge model that mimics naturally occurring viral transmission, we tested the efficacy of a multimeric receptor binding domain (RBD) particle-display based vaccine candidate. While MERS-CoV was transmitted to naïve animals exposed to virus-inoculated llamas, immunization induced robust virus-neutralizing antibody responses and prevented transmission in 1/3 vaccinated, in-contact animals. Our exploratory study supports further improvement of the RBD-based vaccine to prevent zoonotic spillover of MERS-CoV.ca
dc.format.extent5ca
dc.language.isoengca
dc.publisherBMCca
dc.relation.ispartofOne Health Outlookca
dc.rightsAttribution 4.0 Internationalca
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleProtective efficacy of an RBD-based Middle East respiratory syndrome coronavirus (MERS-CoV) particle vaccine in llamasca
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.relation.projectIDEC/PF7/115760/EU/Zoonotic Anticipation and Preparedness Initiative/ZAPIca
dc.relation.projectIDEC/H2020/731014/EU/Veterinary Biocontained facility Network for excellence in animal infectiology research and experimentation /VetBioNetca
dc.subject.udc619ca
dc.identifier.doihttps://doi.org/10.1186/s42522-022-00068-9ca
dc.contributor.groupSanitat Animalca


Fitxers en aquest element

 
 

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Attribution 4.0 International
Excepte que s'indiqui una altra cosa, la llicència de l'ítem es descriu com http://creativecommons.org/licenses/by/4.0/
Comparteix a TwitterComparteix a LinkedinComparteix a FacebookComparteix a TelegramComparteix a WhatsappImprimeix